CSL Limited (CMXHF)
OTCMKTS · Delayed Price · Currency is USD
130.02
-4.98 (-3.69%)
Sep 14, 2025, 8:00 PM EDT
CSL Limited Market Cap
CSL Limited has a market cap or net worth of $66.01 billion as of September 15, 2025. Its market cap has decreased by -33.29% in one year.
Market Cap
66.01B
Enterprise Value
77.62B
Revenue
15.56B
Ranking
n/a
PE Ratio
21.99
Stock Price
$130.02
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 230.16M to 66.01B, an increase of 28,581.24%. That is a compound annual growth rate of 19.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 65.18B | -22.75% |
| Dec 31, 2024 | 84.38B | -10.61% |
| Dec 29, 2023 | 94.40B | 0.09% |
| Dec 30, 2022 | 94.31B | -6.81% |
| Dec 31, 2021 | 101.20B | 1.81% |
| Dec 31, 2020 | 99.40B | 13.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |